Table 4.
In‐Hospital and 30‐Day Outcomes According to MI Type and Sex
| STEMI | NSTEMI | |||||
|---|---|---|---|---|---|---|
| Male (n=5114) | Female (n=1317) | P Value | Male (n=5316) | Female (n=1704) | P Value | |
| In‐hospital outcomes | ||||||
| Total mortality | 5.7 (292) | 8.4 (110) | <0.001 | 0.7 (39) | 1.1 (18) | 0.20 |
| Cardiogenic shock | 5.5 (280) | 8.4 (110) | <0.001 | 0.6 (32) | 1.2 (21) | 0.009 |
| Stroke | 0.9 (44) | 0.6 (8) | 0.36 | 0.2 (12) | 0.2 (3) | 0.70 |
| New or recurrent MI | 1.1 (54) | 1.3 (17) | 0.47 | 0.6 (34) | 1.0 (17) | 0.13 |
| Major bleeding | 1.8 (93) | 3.4 (45) | <0.001 | 0.7 (35) | 1.3 (23) | 0.006 |
| 30‐d outcomes | ||||||
| Total mortality | 6.3 (324) | 9.3 (122) | <0.001 | 1.2 (65) | 1.5 (26) | 0.34 |
| MACE | 8.8 (452) | 11.8 (155) | 0.001 | 3.2 (170) | 3.9 (67) | 0.14 |
| MACCE | 9.5 (485) | 12.5 (164) | 0.001 | 3.4 (179) | 4.2 (71) | 0.12 |
| Major bleeding | 2.3 (117) | 4.0 (53) | <0.001 | 0.2 (12) | 0.5 (8) | 0.10 |
Values are % (number) or median [IQR]. IQR indicates interquartile range; MACCE, major cardiovascular and cerebrovascular events; MACE, major cardiovascular events; MI, myocardial infarction; NSTEMI, non–ST‐segment–elevation myocardial infarction; ST‐segment–elevation myocardial infarction.